Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Optimizing beta-lactam pharmacodynamics against Pseudomonas aeruginosa in adult cystic fibrosis patients.

Optimizing beta-lactam pharmacodynamics against Pseudomonas aeruginosa in adult cystic fibrosis patients.

Resource Type

CF Research News

Authors

Thompson RZ
Martin CA
Burgess DR
Rutter WC
Burgess DS

References

J Cyst Fibros. 2016 Apr 27. pii: S1569-1993(16)30019-4.

Document

PDF icon CF Research News article [1]

Link

Scientific abstract [2]

Theme

Microbiology [3]

Keywords

Beta-lactam [4]
Continuous-infusion [5]
Pharmacodynamics [6]
Pharmacokinetics [7]
Prolonged infusion [8]
Pseudomonas aeruginosa [9]

Date

Friday, April 1, 2016

Featured resource article

Yes
Source URL:https://www.ecfs.eu/research-article/optimizing-beta-lactam-pharmacodynamics-against-pseudomonas-aeruginosa-adult-cystic

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-15-00366R2_FINAL_Burgess_15082016.pdf [2] http://www.ncbi.nlm.nih.gov/pubmed/?term=OPTIMISING%20BETA-LACTAM%20PHARMACODYNAMICS%20AGAINST%20PSEUDOMONAS%20AERUGINOSA%20IN%20ADULT%20CYSTIC%20FIBROSIS%20PATIENTS [3] https://www.ecfs.eu/research-article-themes/microbiology [4] https://www.ecfs.eu/research-article-keywords/beta-lactam [5] https://www.ecfs.eu/research-article-keywords/continuous-infusion [6] https://www.ecfs.eu/research-article-keywords/pharmacodynamics [7] https://www.ecfs.eu/research-article-keywords/pharmacokinetics [8] https://www.ecfs.eu/research-article-keywords/prolonged-infusion [9] https://www.ecfs.eu/research-article-keywords/pseudomonas-aeruginosa